… thyroid cancer (DTC) accounts for the majority of thyroid … attributed to advancements in
detection of papillary thyroid … papillary thyroid cancers (EFVPTC) to non-invasive follicular thyroid …

… Four drugs that have been approved for advanced thyroid cancer treatment after phase III
clinical trial completion include Vandetanib (ZETA), Cabozantinib (EXAM), Sorafenib (…

… The discovery of new biomarkers for thyroid cancer has … of thyroid cancer, thus allowing
more personalized treatments for … treatment of choice in patients with resectable thyroid cancer. …

… diagnosis and treatment of medullary thyroid cancer. … treatment of both differentiated and
medullary thyroid cancers, focusing specifically on newer developments in the field. CA Cancer …

… We also believe that offering all thyroid cancer patients treatment within clinical trials is a
priority whenever possible. When clinical trial participation is not possible, our multidisciplinary …

… a new approach to the treatment of advanced cases of RAI-R … the treatment of advanced,
progressive, and RAI-R thyroid … status of the treatment of advanced thyroid cancer with the use …

… There were 2,940 patients diagnosed with medullary thyroid cancer between 1983 and
2012. The incidence of medullary thyroid cancer increased during this time period from 0.14 to …

… in well-selected patients with DTC to demonstrate the extent to which treatment and follow-up
can be limited without increasing the risk of recurrence and thyroid cancer-related death. …

… The Cancer Genome Atlas (TCGA) … of thyroid cancers into molecular- and genotype-based
subtypes that would predict their prognosis and be helpful in administration of treatment …

… advances made over the years in the treatment of metastatic … cancers harboring specific
alterations (Fig 2). In this article, we discuss the recent advances in the management of thyroid …